A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers
Journal of Clinical EpidemiologyPublished 7 April 2009Open access
Kevin E. Thorpe, Merrick Zwarenstein, Andrew D Oxman, Shaun Treweek, Curt D. Furberg, Douglas G. Altman
Citations1,398
SJR quartileQ1
SJR score3.15
SNIP2.66
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
A tool to assist trialists in making design decisions that are consistent with their trial's stated purpose is proposed, with 10 key domains and which identifies criteria to help researchers determine how pragmatic or explanatory their trial is.
Abstract
We believe that PRECIS is a useful first step toward a tool that can help trialists to ensure that their design decisions are consistent with the stated purpose of the trial.
Keywords
Decision SciencesMedicineHealth Professions
New England Journal of MedicineBeneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
8,368 Citations1991H. J. M. Barnett
Carotid endarterectomy is highly beneficial to patients with recent hemispheric and retinal transient ischemic attacks or nondisabling strokes and ipsilateral high-grade stenosis of the internal carotid artery.
The LancetExternal validity of randomised controlled trials: “To whom do the results of this trial apply?”
2,438 Citations2005Peter M. Rothwell
A review of the determinants of external validity in trial publications and systematic reviews is usually inadequate, a checklist for clinicians is presented, and recommendations for greater consideration of External validity in the design and reporting of RCTs are made.
BMJImproving the reporting of pragmatic trials: an extension of the CONSORT statement
1,829 Citations2008Merrick Zwarenstein, Shaun Treweek +7 more
Eight CONSORT checklist items for reporting of pragmatic trials are recommended, including the background, participants, interventions, outcomes, sample size, blinding, participant flow, and generalisability of the findings.
JAMAPractical Clinical Trials
1,693 Citations2003Sean Tunis, Daniel Stryer +1 more
Increasing the supply of pragmatic or practical clinical trials will depend on the development of a mechanism to establish priorities for these studies, significant expansion of an infrastructure to conduct clinical research within the health care delivery system, more reliance on high-quality evidence by health care decision makers, and a substantial increase in public and private funding forThese studies.
Journal of Clinical EpidemiologyExplanatory and Pragmatic Attitudes in Therapeutical Trials
1,260 Citations2009Daniel Schwartz, J Lellouch
Most therapeutic trials are inadequately formulated from the earliest stages of their conception, and it often occurs that one type of approach is ethically less defensible than the other, or may even be ruled out altogether on ethical grounds.
New England Journal of MedicineLow-Dose Aspirin to Prevent Preeclampsia in Women at High Risk
670 Citations1998Steve N. Caritis, Baha M. Sibai +13 more
In this study, low-dose aspirin did not reduce the incidence of preeclampsia significantly or improve perinatal outcomes in pregnant women at high risk for preeClampsia.
ACP Journal ClubClinical Epidemiology: How to Do Clinical Practice Research
404 Citations2006Carl Heneghan
The book is written by clinicians with experience in generating and answering researchable questions about real-world clinical practice and health care—the prevention, treatment, diagnosis, prognosis, and causes of diseases, the measurement of quality of life, and the effects of innovations in health services.
Clinical Epidemiology: How to Do Clinical Practice Research
305 Citations2005R. Brian Haynes, David L. Sackett +2 more
Becoming a Clinical Researcher * Becoming a Successful Clinician-Investigator * Preparing a Research Protocol to improve its Chances for Success.
The LancetRandomised controlled trial of self-supervised and directly observed treatment of tuberculosis
283 Citations1998Merrick Zwarenstein, Jan H Schoeman +3 more
Treatment for tuberculosis was more successful among self-supervised patients than among those on direct observation, and supportive patient-carer relations rather than the authoritarian surveillance implicit in DO may improve treatment outcomes and help to control tuberculosis.
Journal of Clinical EpidemiologyA simple and valid tool distinguished efficacy from effectiveness studies
211 Citations2006Gerald Gartlehner, Richard A. Hansen +3 more
When applied in a standardized manner, the proposed criteria can provide a valid and simple tool to distinguish effectiveness from efficacy studies and can also be used to determine the external validity of individual studies, given an appropriate population of interest.
Evidence-Based MedicineHaynes RB, Sackett DL, Guyatt GH, et al. Clinical epidemiology: how to do clinical practice research. 3rd edition. Philadelphia, PA: Lippincott Williams & Wilkins, 2006.
79 Citations2006Carl Heneghan
This new edition is aimed at investigators at any stage of their career, “from beginning students to seasoned investigators,” and is a culmination of the authors’ experiences in undertaking clinical epidemiology.
SpineBlind Faith? The Effects of Promoting Active Sick Leave for Back Pain Patients
48 Citations2002Inger B. Scheel, Kåre Birger Hagen +3 more
It is likely that efforts to increase the use of ASL will result in measurable economic benefits or improved health outcomes at the population level, and no significant differences were observed across the three groups for quality of life or patient satisfaction.
Health AffairsA Clinical Research Strategy To Support Shared Decision Making
47 Citations2005Sean Tunis
A more systematic effort to produce evidence about benefits, risks, and costs of alternative treatments will entail establishing research priorities, improving research methods, expanding the research infrastructure, and engaging new funds.